Publication

Internet-based attentional bias modification training as add-on to regular treatment in alcohol and cannabis dependent outpatients: a study protocol of a randomized control trial

Heitmann, J., van Hemel-Ruiter, M. E., Vermeulen, K. M., Ostafin, B. D., MacLeod, C., Wiers, R. W., DeFuentes-Merillas, L., Fledderus, M., Markus, W. & de Jong, P. J., 23-May-2017, In : BMC Psychiatry. 17, 193, 13 p., 193.

Research output: Contribution to journalArticleAcademicpeer-review

APA

Heitmann, J., van Hemel-Ruiter, M. E., Vermeulen, K. M., Ostafin, B. D., MacLeod, C., Wiers, R. W., DeFuentes-Merillas, L., Fledderus, M., Markus, W., & de Jong, P. J. (2017). Internet-based attentional bias modification training as add-on to regular treatment in alcohol and cannabis dependent outpatients: a study protocol of a randomized control trial. BMC Psychiatry, 17(193), [193]. https://doi.org/10.1186/s12888-017-1359-2

Author

Heitmann, Janika ; van Hemel-Ruiter, Madelon E. ; Vermeulen, Karin M. ; Ostafin, Brian D. ; MacLeod, Colin ; Wiers, Reinout W. ; DeFuentes-Merillas, Laura ; Fledderus, Martine ; Markus, Wiebren ; de Jong, Peter J. / Internet-based attentional bias modification training as add-on to regular treatment in alcohol and cannabis dependent outpatients : a study protocol of a randomized control trial. In: BMC Psychiatry. 2017 ; Vol. 17, No. 193.

Harvard

Heitmann, J, van Hemel-Ruiter, ME, Vermeulen, KM, Ostafin, BD, MacLeod, C, Wiers, RW, DeFuentes-Merillas, L, Fledderus, M, Markus, W & de Jong, PJ 2017, 'Internet-based attentional bias modification training as add-on to regular treatment in alcohol and cannabis dependent outpatients: a study protocol of a randomized control trial', BMC Psychiatry, vol. 17, no. 193, 193. https://doi.org/10.1186/s12888-017-1359-2

Standard

Internet-based attentional bias modification training as add-on to regular treatment in alcohol and cannabis dependent outpatients : a study protocol of a randomized control trial. / Heitmann, Janika; van Hemel-Ruiter, Madelon E.; Vermeulen, Karin M.; Ostafin, Brian D.; MacLeod, Colin; Wiers, Reinout W.; DeFuentes-Merillas, Laura; Fledderus, Martine; Markus, Wiebren; de Jong, Peter J.

In: BMC Psychiatry, Vol. 17, No. 193, 193, 23.05.2017.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

Heitmann J, van Hemel-Ruiter ME, Vermeulen KM, Ostafin BD, MacLeod C, Wiers RW et al. Internet-based attentional bias modification training as add-on to regular treatment in alcohol and cannabis dependent outpatients: a study protocol of a randomized control trial. BMC Psychiatry. 2017 May 23;17(193). 193. https://doi.org/10.1186/s12888-017-1359-2


BibTeX

@article{c0b1a42b7a024481bbce7bc398b9528f,
title = "Internet-based attentional bias modification training as add-on to regular treatment in alcohol and cannabis dependent outpatients: a study protocol of a randomized control trial",
abstract = "Background: The automatic tendency to attend to and focus on substance-related cues in the environment (attentional bias), has been found to contribute to the persistence of addiction. Attentional bias modification (ABM) interventions might, therefore, contribute to treatment outcome and the reduction of relapse rates. Based on some promising research findings, we designed a study to test the clinical relevance of ABM as an add-on component of regular intervention for alcohol and cannabis patients.Design/Methods: The current protocol describes a study which will investigate the effectiveness and cost-effectiveness of a newly developed home-delivered, multi-session, internet-based ABM (iABM) intervention as an add-on to treatment as usual (TAU). TAU consists of cognitive behavioural therapy-based treatment according to the Dutch guidelines for the treatment of addiction. Participants (N = 213) will be outpatients from specialized addiction care institutions diagnosed with alcohol or cannabis dependency who will be randomly assigned to one of three conditions: TAU + iABM; TAU + placebo condition; TAU-only. Primary outcome measures are substance use, craving, and rates of relapse. Changes in attentional bias will be measured to investigate whether changes in primary outcome measures can be attributed to the modification of attentional bias. Indices of cost-effectiveness and secondary physical and psychological complaints (depression, anxiety, and stress) are assessed as secondary outcome measures.Discussion: This randomized control trial will be the first to investigate whether a home-delivered, multi-session iABM intervention is (cost-) effective in reducing relapse rates in alcohol and cannabis dependency as an add-on to TAU, compared with an active and a waiting list control group. If proven effective, this ABM intervention could be easily implemented as a home-delivered component of current TAU.",
keywords = "Addiction, Attentional bias modification, eHealth, EXPERIMENTAL MANIPULATION, ADDICTIVE BEHAVIORS, CIGARETTE SMOKERS, PROBLEM DRINKERS, ADOLESCENTS, SUBSTANCE, HEAVY, COGNITION, DISORDER, EXPLICIT",
author = "Janika Heitmann and {van Hemel-Ruiter}, {Madelon E.} and Vermeulen, {Karin M.} and Ostafin, {Brian D.} and Colin MacLeod and Wiers, {Reinout W.} and Laura DeFuentes-Merillas and Martine Fledderus and Wiebren Markus and {de Jong}, {Peter J.}",
year = "2017",
month = may,
day = "23",
doi = "10.1186/s12888-017-1359-2",
language = "English",
volume = "17",
journal = "BMC Psychiatry",
issn = "1471-244X",
publisher = "BMC",
number = "193",

}

RIS

TY - JOUR

T1 - Internet-based attentional bias modification training as add-on to regular treatment in alcohol and cannabis dependent outpatients

T2 - a study protocol of a randomized control trial

AU - Heitmann, Janika

AU - van Hemel-Ruiter, Madelon E.

AU - Vermeulen, Karin M.

AU - Ostafin, Brian D.

AU - MacLeod, Colin

AU - Wiers, Reinout W.

AU - DeFuentes-Merillas, Laura

AU - Fledderus, Martine

AU - Markus, Wiebren

AU - de Jong, Peter J.

PY - 2017/5/23

Y1 - 2017/5/23

N2 - Background: The automatic tendency to attend to and focus on substance-related cues in the environment (attentional bias), has been found to contribute to the persistence of addiction. Attentional bias modification (ABM) interventions might, therefore, contribute to treatment outcome and the reduction of relapse rates. Based on some promising research findings, we designed a study to test the clinical relevance of ABM as an add-on component of regular intervention for alcohol and cannabis patients.Design/Methods: The current protocol describes a study which will investigate the effectiveness and cost-effectiveness of a newly developed home-delivered, multi-session, internet-based ABM (iABM) intervention as an add-on to treatment as usual (TAU). TAU consists of cognitive behavioural therapy-based treatment according to the Dutch guidelines for the treatment of addiction. Participants (N = 213) will be outpatients from specialized addiction care institutions diagnosed with alcohol or cannabis dependency who will be randomly assigned to one of three conditions: TAU + iABM; TAU + placebo condition; TAU-only. Primary outcome measures are substance use, craving, and rates of relapse. Changes in attentional bias will be measured to investigate whether changes in primary outcome measures can be attributed to the modification of attentional bias. Indices of cost-effectiveness and secondary physical and psychological complaints (depression, anxiety, and stress) are assessed as secondary outcome measures.Discussion: This randomized control trial will be the first to investigate whether a home-delivered, multi-session iABM intervention is (cost-) effective in reducing relapse rates in alcohol and cannabis dependency as an add-on to TAU, compared with an active and a waiting list control group. If proven effective, this ABM intervention could be easily implemented as a home-delivered component of current TAU.

AB - Background: The automatic tendency to attend to and focus on substance-related cues in the environment (attentional bias), has been found to contribute to the persistence of addiction. Attentional bias modification (ABM) interventions might, therefore, contribute to treatment outcome and the reduction of relapse rates. Based on some promising research findings, we designed a study to test the clinical relevance of ABM as an add-on component of regular intervention for alcohol and cannabis patients.Design/Methods: The current protocol describes a study which will investigate the effectiveness and cost-effectiveness of a newly developed home-delivered, multi-session, internet-based ABM (iABM) intervention as an add-on to treatment as usual (TAU). TAU consists of cognitive behavioural therapy-based treatment according to the Dutch guidelines for the treatment of addiction. Participants (N = 213) will be outpatients from specialized addiction care institutions diagnosed with alcohol or cannabis dependency who will be randomly assigned to one of three conditions: TAU + iABM; TAU + placebo condition; TAU-only. Primary outcome measures are substance use, craving, and rates of relapse. Changes in attentional bias will be measured to investigate whether changes in primary outcome measures can be attributed to the modification of attentional bias. Indices of cost-effectiveness and secondary physical and psychological complaints (depression, anxiety, and stress) are assessed as secondary outcome measures.Discussion: This randomized control trial will be the first to investigate whether a home-delivered, multi-session iABM intervention is (cost-) effective in reducing relapse rates in alcohol and cannabis dependency as an add-on to TAU, compared with an active and a waiting list control group. If proven effective, this ABM intervention could be easily implemented as a home-delivered component of current TAU.

KW - Addiction

KW - Attentional bias modification

KW - eHealth

KW - EXPERIMENTAL MANIPULATION

KW - ADDICTIVE BEHAVIORS

KW - CIGARETTE SMOKERS

KW - PROBLEM DRINKERS

KW - ADOLESCENTS

KW - SUBSTANCE

KW - HEAVY

KW - COGNITION

KW - DISORDER

KW - EXPLICIT

U2 - 10.1186/s12888-017-1359-2

DO - 10.1186/s12888-017-1359-2

M3 - Article

C2 - 28535815

VL - 17

JO - BMC Psychiatry

JF - BMC Psychiatry

SN - 1471-244X

IS - 193

M1 - 193

ER -

ID: 42715146